retatrutide triple agonist gip glp-1 glucagon phase 2 obesity trial ADA 2026: Retatrutide Revolution

The ADA/EASD consensus report 4 highlights the use of DDP-4 inhibitors when intermediate efficacy for glucose lowering is required and where weight management goals would prefer a weight-neutral approach

Intra-articular injection of Cit-AuNRs@Anti-TRPV1 alleviates cartilage degradation by activating TRPV1 to inhibit ferroptosis in chondrocytes, reduces pain and improves physical activity in mice with medial meniscus instability-induced OA

Liraglutide (Injectable) Shows More Promise The ELAD Phase 2b trial of injectable liraglutide in mild Alzheimers disease showed more encouraging signals: brain volume loss in memory-related regions was reduced by nearly 50% compared to placebo over one year

With Whitelight Sublingual Spray , you can achieve healthy system, looking and feeling young and fairer skin rolled into one